Soumen Chakraborty

822 total citations
27 papers, 635 citations indexed

About

Soumen Chakraborty is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Soumen Chakraborty has authored 27 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Hematology and 7 papers in Genetics. Recurrent topics in Soumen Chakraborty's work include Chronic Myeloid Leukemia Treatments (7 papers), Acute Myeloid Leukemia Research (6 papers) and RNA modifications and cancer (6 papers). Soumen Chakraborty is often cited by papers focused on Chronic Myeloid Leukemia Treatments (7 papers), Acute Myeloid Leukemia Research (6 papers) and RNA modifications and cancer (6 papers). Soumen Chakraborty collaborates with scholars based in India, United States and Belgium. Soumen Chakraborty's co-authors include Giuseppina Nucifora, Vitalyi Senyuk, Yiqing Chi, Kislay K. Sinha, Silvia Buonamici, Anjan Kumar Pradhan, Tohru Sugimoto, Tomoyuki Ichimura, Kazuo Hasegawa and Agatheeswaran Subramaniam and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Soumen Chakraborty

25 papers receiving 631 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Soumen Chakraborty India 13 434 197 88 82 80 27 635
Sheryl M. Gough United States 12 477 1.1× 231 1.2× 66 0.8× 42 0.5× 90 1.1× 23 658
Koichi R. Katsumura United States 18 578 1.3× 257 1.3× 170 1.9× 98 1.2× 107 1.3× 24 863
Ashwini Yenamandra United States 9 363 0.8× 100 0.5× 37 0.4× 61 0.7× 107 1.3× 21 523
Tatsuo Abe Japan 14 339 0.8× 125 0.6× 152 1.7× 82 1.0× 119 1.5× 26 660
Joanne I. Hsu United States 7 346 0.8× 255 1.3× 54 0.6× 61 0.7× 87 1.1× 15 630
Anand Jillella United States 12 456 1.1× 379 1.9× 136 1.5× 38 0.5× 166 2.1× 48 841
Naïs Prade France 7 197 0.5× 176 0.9× 90 1.0× 78 1.0× 95 1.2× 8 395
Daniel P. Sejas United States 10 475 1.1× 146 0.7× 85 1.0× 67 0.8× 124 1.6× 10 641
Parham Ramezani-Rad United States 9 262 0.6× 124 0.6× 263 3.0× 57 0.7× 105 1.3× 19 615
Rika Kanezaki Japan 11 198 0.5× 163 0.8× 68 0.8× 48 0.6× 47 0.6× 19 387

Countries citing papers authored by Soumen Chakraborty

Since Specialization
Citations

This map shows the geographic impact of Soumen Chakraborty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soumen Chakraborty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soumen Chakraborty more than expected).

Fields of papers citing papers by Soumen Chakraborty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soumen Chakraborty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soumen Chakraborty. The network helps show where Soumen Chakraborty may publish in the future.

Co-authorship network of co-authors of Soumen Chakraborty

This figure shows the co-authorship network connecting the top 25 collaborators of Soumen Chakraborty. A scholar is included among the top collaborators of Soumen Chakraborty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soumen Chakraborty. Soumen Chakraborty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Majee, Sutapa Biswas, et al.. (2025). PTBP2 promotes cell survival and autophagy in chronic myeloid leukemia by stabilizing BNIP3. Cell Death and Disease. 16(1). 195–195.
2.
Mandal, Ardhendu & Soumen Chakraborty. (2025). Biogenesis and implication of miRNAs in the development of diseases and their theranostic inhibitions. Journal of Drug Delivery and Therapeutics. 15(8). 267–293.
3.
Singh, Vivek Kumar, et al.. (2022). EVI1 upregulates PTGS1 (COX1) and decreases the action of tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia cells. International Journal of Hematology. 117(1). 110–120. 4 indexed citations
4.
Senapati, Shantibhusan, et al.. (2022). AKT inhibition sensitizes EVI1 expressing colon cancer cells to irinotecan therapy by regulating the Akt/mTOR axis. Cellular Oncology. 45(4). 659–675. 3 indexed citations
5.
Subramaniam, Agatheeswaran, et al.. (2019). PTBP2 exon 10 inclusion is associated with the progression of CML and it is BCR-ABL1 dependent. The International Journal of Biochemistry & Cell Biology. 109. 69–75. 6 indexed citations
6.
Kumar, T. R. Santhosh, et al.. (2018). Ecotropic viral integration site 1 promotes metastasis independent of epithelial mesenchymal transition in colon cancer cells. Cell Death and Disease. 9(2). 18–18. 17 indexed citations
7.
Majee, Sutapa Biswas, et al.. (2016). Dual transcripts of BCR-ABL & different polymorphisms in chronic myeloid leukaemia patients. The Indian Journal of Medical Research. 143(Suppl 1). S136–S141. 5 indexed citations
8.
Subramaniam, Agatheeswaran & Soumen Chakraborty. (2016). MEF2C and CEBPA: Possible co-regulators in chronic myeloid leukemia disease progression. The International Journal of Biochemistry & Cell Biology. 77(Pt A). 165–170. 8 indexed citations
9.
Subramaniam, Agatheeswaran, et al.. (2016). Ecotropic viral integration site I regulates alpha1, 6-fucosyl transferase expression and blocks erythropoiesis in chronic myeloid leukemia. Leukemia & lymphoma. 58(8). 1941–1947. 3 indexed citations
10.
Panda, Aditya K., et al.. (2013). EVI1 targets ΔNp63 and upregulates the cyclin dependent kinase inhibitor p21 independent of p53 to delay cell cycle progression and cell proliferation in colon cancer cells. The International Journal of Biochemistry & Cell Biology. 45(8). 1568–1576. 17 indexed citations
11.
Pradhan, Anjan Kumar, et al.. (2011). EVI1 up-regulates the stress responsive gene SIRT1 which triggers deacetylation and degradation of EVI1. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1809(4-6). 269–275. 8 indexed citations
12.
Pradhan, Anjan Kumar, et al.. (2011). Acetylation of the Proto-Oncogene EVI1 Abrogates Bcl-xL Promoter Binding and Induces Apoptosis. PLoS ONE. 6(9). e25370–e25370. 25 indexed citations
13.
Laricchia‐Robbio, Leopoldo, Donglan Li, Ciro R. Rinaldi, et al.. (2006). Point Mutations in Two EVI1 Zn Fingers Abolish EVI1-GATA1 Interaction and Allow Erythroid Differentiation of Murine Bone Marrow Cells. Molecular and Cellular Biology. 26(20). 7658–7666. 58 indexed citations
14.
Buonamici, Silvia, Soumen Chakraborty, Vitalyi Senyuk, & Giuseppina Nucifora. (2003). The role of EVI1 in normal and leukemic cells. Blood Cells Molecules and Diseases. 31(2). 206–212. 58 indexed citations
15.
Senyuk, Vitalyi, Kislay K. Sinha, Soumen Chakraborty, Silvia Buonamici, & Giuseppina Nucifora. (2003). P/CAF and GCN5 acetylate the AML1/MDS1/EVI1 fusion oncoprotein. Biochemical and Biophysical Research Communications. 307(4). 980–986. 9 indexed citations
16.
Chi, Yiqing, Vitalyi Senyuk, Soumen Chakraborty, & Giuseppina Nucifora. (2003). EVI1 Promotes Cell Proliferation by Interacting with BRG1 and Blocking the Repression of BRG1 on E2F1 Activity. Journal of Biological Chemistry. 278(50). 49806–49811. 36 indexed citations
17.
Senyuk, Vitalyi, Soumen Chakraborty, Fady M. Mikhail, et al.. (2002). The leukemia-associated transcription repressor AML1/MDS1/EVI1 requires CtBP to induce abnormal growth and differentiation of murine hematopoietic cells. Oncogene. 21(20). 3232–3240. 52 indexed citations
18.
Chakraborty, Soumen, Vitalyi Senyuk, & Giuseppina Nucifora. (2001). Genetic lesions and perturbation of chromatin architecture: A road to cell transformation. Journal of Cellular Biochemistry. 82(2). 310–325. 17 indexed citations
19.
20.
Koizumi, Toshiyuki, et al.. (2000). True. British Journal of Cancer. 82(10). 1682–1688. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sheryl M. Gough Breakdown of academic impact, for papers by Koichi R. Katsumura Breakdown of academic impact, for papers by Ashwini Yenamandra Breakdown of academic impact, for papers by Tatsuo Abe Breakdown of academic impact, for papers by Joanne I. Hsu Breakdown of academic impact, for papers by Anand Jillella Breakdown of academic impact, for papers by Naïs Prade Breakdown of academic impact, for papers by Daniel P. Sejas Breakdown of academic impact, for papers by Parham Ramezani-Rad Breakdown of academic impact, for papers by Rika Kanezaki
Rankless by CCL
2026